Partow Kebriaei
About
Partow Kebriaei is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology.
According to data from OpenAlex, Partow Kebriaei has authored 396 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 275 papers in Hematology, 157 papers in Public Health, Environmental and Occupational Health and 142 papers in Oncology. Recurrent topics in Partow Kebriaei's work include Acute Lymphoblastic Leukemia research (150 papers), Hematopoietic Stem Cell Transplantation (144 papers) and Acute Myeloid Leukemia Research (102 papers). Partow Kebriaei is often cited by papers focused on Acute Lymphoblastic Leukemia research (150 papers), Hematopoietic Stem Cell Transplantation (144 papers) and Acute Myeloid Leukemia Research (102 papers). Partow Kebriaei collaborates with scholars based in United States, Canada and Germany. Partow Kebriaei's co-authors include Richard E. Champlin, Elizabeth J. Shpall, Farhad Ravandi, Hagop M. Kantarjian, Laurence J.N. Cooper, Helen Huls, David L. Rimm, Jon S. Morrow, Carol D. Cianci and Katayoun Rezvani and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
In The Last Decade
Partow Kebriaei
373 papers receiving 11.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Partow Kebriaei United States | 50 | 5.9k | 4.8k | 2.9k | 2.9k | 2.1k | 396 | 11.8k | ||
| Alan S. Wayne United States | 39 | 4.4k 0.8× | 2.3k 0.5× | 1.3k 0.5× | 1.9k 0.7× | 2.4k 1.1× | 170 | 8.4k | ||
| Nancy Bunin United States | 37 | 4.6k 0.8× | 2.6k 0.5× | 1.4k 0.5× | 1.5k 0.5× | 2.1k 1.0× | 141 | 8.0k | ||
| David T. Teachey United States | 49 | 10.6k 1.8× | 2.9k 0.6× | 2.6k 0.9× | 3.8k 1.3× | 5.0k 2.4× | 192 | 15.6k | ||
| Katayoun Rezvani United States | 51 | 5.5k 0.9× | 3.6k 0.7× | 579 0.2× | 2.8k 1.0× | 4.9k 2.4× | 216 | 11.2k | ||
| Dario Campana United States | 85 | 7.6k 1.3× | 9.1k 1.9× | 8.7k 3.0× | 5.2k 1.8× | 7.7k 3.7× | 287 | 22.5k | ||
| Noelle V. Frey United States | 34 | 7.6k 1.3× | 1.5k 0.3× | 869 0.3× | 2.2k 0.8× | 2.7k 1.3× | 160 | 9.6k | ||
| Adam Bagg United States | 37 | 7.0k 1.2× | 2.0k 0.4× | 517 0.2× | 3.8k 1.3× | 3.2k 1.5× | 216 | 11.9k | ||
| Shelly Heimfeld United States | 38 | 2.9k 0.5× | 4.1k 0.8× | 549 0.2× | 3.2k 1.1× | 3.5k 1.7× | 107 | 9.8k | ||
| Shannon L. Maude United States | 33 | 7.7k 1.3× | 1.2k 0.2× | 1.4k 0.5× | 2.1k 0.7× | 2.5k 1.2× | 107 | 9.2k | ||
| Constance M. Yuan United States | 31 | 4.2k 0.7× | 915 0.2× | 738 0.3× | 1.5k 0.5× | 1.7k 0.8× | 121 | 5.9k |
Countries citing papers authored by Partow Kebriaei
Since
Specialization
Citations
This map shows the geographic impact of Partow Kebriaei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Partow Kebriaei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Partow Kebriaei more than expected).
Fields of papers citing papers by Partow Kebriaei
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Partow Kebriaei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Partow Kebriaei. The network helps show where Partow Kebriaei may publish in the future.
Co-authorship network of co-authors of Partow Kebriaei
This figure shows the co-authorship network connecting the top 25 collaborators of Partow Kebriaei. A scholar is included among the top collaborators of Partow Kebriaei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Partow Kebriaei. Partow Kebriaei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Mehta, Rohtesh S., Yosra Aljawai, Partow Kebriaei, et al.. (2025). The Impact of Isolated HLA-DQB1 Mismatch and Donor Age in Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide. Transplantation and Cellular Therapy. 31(11). 920.e1–920.e14.
2.
Short, Nicholas J., Elias Jabbour, Walid Macaron, et al.. (2025). Prognostic impact of early NGS MRD dynamics and cytomolecular risk in newly diagnosed B-cell ALL. Blood Cancer Journal. 15(1). 169–169.
3.
Aljawai, Yosra, Jeremy Ramdial, Gabriela Rondón, et al.. (2025). Outcomes of haploidentical vs mismatched unrelated donor HCT with posttransplant cyclophosphamide prophylaxis. Blood Advances. 9(15). 4023–4036.
4.
Lontos, Konstantinos, Rima M. Saliba, Rashmi Kanagal‐Shamanna, et al.. (2025). TP53-mutant variant allele frequency and cytogenetics determine prognostic groups in MDS/AML for transplantation. Blood Advances. 9(11). 2845–2854.
5.
Ravandi, Farhad, Jayastu Senapati, Nitin B. Jain, et al.. (2024). Longitudinal follow up of a phase 2 trial of venetoclax added to hyper-CVAD, nelarabine and pegylated asparaginase in patients with T-cell acute lymphoblastic leukemia and lymphoma. Leukemia. 38(12). 2717–2721.
6.
Westin, Jason R., Loretta J. Nastoupil, Ranjit Nair, et al.. (2024). Factors associated with manufacturing failure of commercial CD19 CAR-T cell products for large b cell lymphoma (LBCL).. Journal of Clinical Oncology. 42(16_suppl). 7044–7044.
7.
Joseph, Jacinth, Samer A. Srour, Denái R. Milton, et al.. (2023). Transplantation Outcomes of Myelofibrosis with Busulfan and Fludarabine Myeloablative Conditioning. Transplantation and Cellular Therapy. 29(12). 770.e1–770.e6.
8.
Saliba, Rima M., Christopher G. Kanakry, Shahinaz M. Gadalla, et al.. (2023). Effect of donor age in patients with acute myeloid leukemia undergoing haploidentical hematopoietic cell transplantation vary by conditioning intensity and recipient age. American Journal of Hematology. 99(1). 38–47.
9.
Mehta, Rohtesh S., Jeremy Ramdial, David Marín, et al.. (2023). Impact of Donor Age in Haploidentical-Post-Transplantation Cyclophosphamide versus Matched Unrelated Donor Post-Transplantation Cyclophosphamide Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia. Transplantation and Cellular Therapy. 29(6). 377.e1–377.e7.
10.
Pasvolsky, Oren, Partow Kebriaei, Bijal Shah, Elias Jabbour, & Nitin Jain. (2023). Chimeric antigen receptor T-cell therapy for adult B-cell acute lymphoblastic leukemia: state-of-the-(C)ART and the road ahead. Blood Advances. 7(14). 3350–3360.
11.
Short, Nicholas J., Elias Jabbour, Walid Macaron, et al.. (2023). Ultrasensitive NGS MRD assessment in Ph+ ALL : Prognostic impact and correlation with RT‐PCR for BCR::ABL1. American Journal of Hematology. 98(8). 1196–1203.
12.
Pasvolsky, Oren, Denái R. Milton, Mark R. Tanner, et al.. (2022). Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple Myeloma. Transplantation and Cellular Therapy. 28(11). 752.e1–752.e6.
13.
Mehta, Rohtesh S., Rima M. Saliba, Kai Cao, et al.. (2017). Ex Vivo Mesenchymal Precursor Cell–Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery. Biology of Blood and Marrow Transplantation. 23(8). 1359–1366.
14.
Hurton, Lenka V., Harjeet Singh, Amer Najjar, et al.. (2016). Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells. Proceedings of the National Academy of Sciences. 113(48). E7788–E7797.
15.
Liadi, Ivan, Harjeet Singh, Gabrielle Romain, et al.. (2015). Individual Motile CD4+ T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells. Cancer Immunology Research. 3(5). 473–482.
16.
Ravandi, Farhad, Megan Othus, Susan O’Brien, et al.. (2015). Multi-Center US Intergroup Study of Intensive Chemotherapy Plus Dasatinib Followed By Allogeneic Stem Cell Transplant in Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Younger Than 60. Blood. 126(23). 796–796.
17.
Leen, Ann M., Catherine M. Bollard, Adam Mendizabal, et al.. (2013). Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation. Blood. 121(26). 5113–5123.
18.
Singh, Harjeet, Matthew J. Figliola, Margaret J. Dawson, et al.. (2011). Reprogramming CD19-Specific T Cells with IL-21 Signaling Can Improve Adoptive Immunotherapy of B-Lineage Malignancies. Cancer Research. 71(10). 3516–3527.
19.
Kebriaei, Partow. (2011). Chimeric antibody receptors (CARs): Driving T-cell specificity to enhance anti-tumor immunity. Frontiers in Bioscience-Scholar. S4(1). 520–520.
20.
Ravandi, Farhad & Partow Kebriaei. (2009). Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Hematology/Oncology Clinics of North America. 23(5). 1043–1063.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Alan S. Wayne Breakdown of academic impact, for papers by Nancy Bunin Breakdown of academic impact, for papers by David T. Teachey Breakdown of academic impact, for papers by Katayoun Rezvani Breakdown of academic impact, for papers by Dario Campana Breakdown of academic impact, for papers by Noelle V. Frey Breakdown of academic impact, for papers by Adam Bagg Breakdown of academic impact, for papers by Shelly Heimfeld Breakdown of academic impact, for papers by Shannon L. Maude Breakdown of academic impact, for papers by Constance M. Yuan